Introduction
============

Experimental animal models play an important role in studying human atherosclerosis. Until now, many animals have been used in this field, including nonhuman primates, pigs, rabbits, and mice^[@bib1],\ [@bib2])^. Nowadays, genetically modified mice have become the most popular animal model for atherosclerosis research^[@bib3])^. Which animals researchers use depends on the experimental purposes; however, there are general essential principles that need to be considered when choosing animals: (1) animals should be easy to acquire and maintain at a reasonable cost, easy to handle, and the proper size to allow for all anticipated experimental manipulations, (2) the animal should reproduce in a laboratory setting and have a well-defined genetic background, and (3) the animal model should share with humans the most important aspects of lipid metabolism and cardiovascular pathophysiology^[@bib4])^. Although no animal model meets all of these requirements, rabbits are still valuable models for studying atherosclerosis. Indeed, rabbits were the first used animal model for the study of human atherosclerosis. Pioneer studies to establish rabbit atherosclerosis models were performed by two Russian scientists more than a century ago. In 1908, a Russian physician, Ignatowski, fed rabbits with a diet enriched in animal proteins (milk, meat and eggs) and observed intimal lesions with large clear cell (now referred to as foam cell) accumulation in the aorta^[@bib5])^. Later, a Russian experimental pathologist, Anitschkow, used a cholesterol diet dissolved in vegetable oil to produce aortic atherosclerosis in rabbits similar with that seen in humans and proposed a causal role of cholesterol in atherosclerosis^[@bib6])^. Their studies established the basis of atherosclerosis theory that in both humans and experimental animals, dietary cholesterol can induce atherosclerosis. Rabbit models were widely used and disclosed most of the pathophysiological significance between human atherosclerosis and lipid metabolism such as the discovery of LDL receptors and development of statins, the most prescribed lipid-lowering drugs in the world^[@bib7])^. Compared with mice, rabbits have many features similar with humans, which facilitates the studies of lipid metabolism and atherosclerosis (**[Table 1](#T1){ref-type="table"}**). For example, like humans but unlike mice, rabbits have abundant plasma cholesteryl ester transfer protein (CETP), which facilitates studying the relationship between CETP and atherosclerosis^[@bib8])^. For a long time, it has been controversial whether inhibition of CETP is beneficial for the treatment of atherosclerosis. Concurrently, human clinical trials of CETP inhibitors were generally unsuccessful due to off-target side effects (torcetrapib) or lack of efficacy (dalcetrapib and evacetrapib)^[@bib9]--[@bib12])^. Merck\'s anacetrapib was reported to be effective in reducing cardiovascular events in a Phase III clinical trial^[@bib13])^. Recently, we successfully generated CETP KO rabbits using ZFN methods and demonstrated that genetic deletion of the CETP gene in rabbits protects against diet-induced atherosclerosis^[@bib14])^.

###### Comparison of lipid and lipoprotein metabolism features

                                        Human                           Rabbit                          Mouse
  ------------------------------------- ------------------------------- ------------------------------- -----------------------------
  Major plasma lipoproteins             LDL                             LDL                             HDL
  CETP                                  Abundant                        Abundant                        None
  Hepatic apoB mRNA editing             No                              No                              Yes
  apoB-48                               Chylomicrons                    Chylomicrons                    VLDLs/LDLs and Chylomicrons
  apoB-100                              Can be bound to apo(a)          Can be bound to apo(a)          Cannot be bound to apo(a)
  HDL                                   Heterogeneous                   Heterogeneous                   Homogeneous
  apoAII                                Dimer                           Absent                          Monomer
  Hepatic LDL receptor activity         Down-regulated                  Down-regulated                  Usually high
  Hepatic lipase                        High, liver-bound               Low, liver-bound                High, 70% in circulation
  Cholesterol pool                      Mainly from hepatic synthesis   Mainly from hepatic synthesis   Mainly from dietary origin
  Excretion of bile acid                Low                             Low                             High
  Response to a high cholesterol diet   Sensitive                       Sensitive                       Resistant

Although the rabbit model has brought about many breakthroughs in the history of atherosclerosis research^[@bib7])^, apolipoprotein E (apo E) and LDL receptor gene knock-out (KO) mice became the major models to study atherosclerosis from 2000^[@bib7])^. In spite of this, rabbits are the second most-used animal models for the study of atherosclerosis based on research papers published in high-profile journals. The importance of using rabbits has been extensively reviewed in previous articles^[@bib4],\ [@bib7],\ [@bib15]--[@bib17])^, and in this short review, we will focus on how to use rabbits for cardiovascular research.

Methods to Induce Atherosclerosis in Rabbits
============================================

In general, aortic atherosclerotic lesions in rabbits can be easily induced by feeding a high cholesterol diet alone or in combination with arterial balloon injury. Compared with other animals, especially rodents, laboratory rabbits are sensitive to a high cholesterol diet and rapidly develop hypercholesterolemia^[@bib7])^. Therefore, it is much easier to induce hypercholesterolemia in rabbits than in other animals by feeding a high cholesterol diet. Dietary cholesterol can range from 0.3%∼1% depending on the research purposes. We recommend the use of 0.3∼0.5% cholesterol in the diet for most experiments because it produces less health problems such as liver toxicity. If cholesterol content is too high (\> 1%), rabbits develop massive hypercholesterolemia (plasma cholesterol levels \> 1200 mg/dl), which is never observed in humans. Plasma cholesterol levels that are too high often lead to systemic lipid accumulation and liver dysfunction in rabbits, which is often criticized as "not physiological" by many researchers. Therefore, it is not recommended to feed rabbits with a diet containing cholesterol higher than 1% for more than 4 weeks. In addition to cholesterol, oil, such as soybean or corn oil, is essential in the diet. This is because oil in the diet helps in absorption of intestinal cholesterol. There are many commercially available dietary oils that may be used for rabbit experiments. However, coconut oil, as an exception, is rich in saturated fatty acids, unlike other vegetable dietary oils that are rich in polyunsaturated fatty acids. Coconut oil can be used for insulin resistance studies^[@bib18],\ [@bib19])^. It should be noted that cholesterol diets without the addition of oil lead to mobilization of internal fat tissue for absorption of exogenous cholesterol^[@bib4])^; therefore, rabbits become extremely thin and sometimes develop cachexia. On a high cholesterol diet, rabbits develop aortic atherosclerosis by 12∼16 weeks. For more advanced lesions, the length of cholesterol diet feeding can be extended for more than 28 weeks^[@bib20])^. As rabbits are out-bred animals, it is not unusual for some rabbits to exhibit inert responses to a high cholesterol diet, and are referred to as hypo-responders^[@bib21])^. Watanabe heritable hyperlipidemic (WHHL) rabbits are genetically deficient in LDL receptor functions, and develop hypercholesterolemia and atherosclerosis spontaneously on a chow diet^[@bib22])^. Although it is difficult to transport WHHL rabbits to many institutions, it is now possible to produce LDL receptor knock-out rabbits by CRISPR-Cas9 methods. Recently, we successfully generated LDL receptor KO rabbits that show a similar phenotype with WHHL rabbits (Liang *et al.* unpublished data).

Methods to Analyze Atherosclerosis
==================================

The rabbit aorta is mainly used for the analysis of atherosclerosis because it is easy to isolate and both gross and microscopic evaluation of aortic lesion size and quality can be made. The lesions usually start to form from the aortic arch followed by the intercostal orifice area and thoracic aorta. Abdominal aortic lesions are less frequently seen, which is different from human atherosclerosis. As the aortic lesions are large, it is also possible to collect a part of the lesions to analyze protein and mRNA expression using Western blotting and RT-PCR methods. If these analyses are required, these samples should be immediately frozen in nitrogen liquid and stocked at −80°C.

Gross analysis usually requires Sudan IV staining to visualize atherosclerotic lesions followed by image analysis to calculate the lesion percentage of each aortic segment^[@bib23])^ (**[Fig. 1](#F1){ref-type="fig"}**). Based on the gross observations, one can decide which parts to select to make paraffin-embedded sections for microscopic observations. Usually, the whole aortic arch and thoracic aorta will be cut into 10--12 segments (1-mm thick) for paraffin embedding^[@bib23])^. Serial sections can be routinely used for hematoxylin-eosin (HE) staining and elastic van Gieson (EVG). HE staining is essential to evaluate the quality of the lesions such as cellular and extracellular matrix component features and plaque vulnerability. To quantitate the intimal lesion area on the sections, EVG staining is useful because it can visualize the internal elastic lamina (IEL), making it easy to measure intimal lesions and medial lesions separately. Paraffin sections can be used for direct immunohistochemical staining in most cases using most commercial antibodies. Routinely, it is essential to evaluate macrophages and smooth muscle cells using RAM-1 and smooth muscle α-actin antibodies (**[Fig. 1](#F1){ref-type="fig"}**).

![Representative aortic lesions in cholesterol-fed rabbits. A. Gross lesions of the aorta stained by Sudan IV (visualized as red area). B. Representative micrographs of early stage lesions (fatty streaks). C. A typical fibrous plaque with a lipid core covered by a fibrous cap. Serial paraffin sections of the aortic arch were stained with hematoxylin and eosin (HE) and elastica van Gieson (EVG), or immunohistochemically stained with monoclonal antibodies (mAbs) against either macrophages (M?) or α-smooth muscle actin for smooth muscle cells (SMC).](jat-25-213-g001){#F1}

If analysis of protein and mRNA expression is required, a piece of fresh tissue proceeded in liquid nitrogen at the time of aorta collection should be collected. In hypercholesterolemic rabbits, iliac arteries, carotid arteries and subclavian arteries seldom exhibit atherosclerosis; however, coronary lesions of rabbits can be observed at the large branches such as the left and right coronary arteries. The method for rabbit coronary lesion analysis has been described in detail in the previous review^[@bib7])^. Balloon injury of aortas or wire injury of iliac arteries in rabbits is sometimes used to produce intimal lesion models. However, these lesions induced by injuries are mainly composed of proliferating smooth muscle cells forming so-called "neo-intima", which is different from fatty streaks induced by cholesterol diet feeding. However, balloon injury may also be performed in cholesterol-fed rabbits, which will accelerate the formation of the lesions^[@bib24])^.

Transgenic Rabbits
==================

In addition to cholesterol-fed rabbits, transgenic (Tg) rabbits have also been used for the study of human cardiovascular disease and lipoprotein metabolism during the last two decades. However, in contrast to Tg mice, Tg rabbits were only used by a few institutions to study atherosclerosis. Elucidation of gene functions in terms of lipoprotein metabolism and atherosclerosis using Tg rabbits was essentially based on the premise that rabbits bear features more similar with those of humans such as metabolism and susceptibility to atherosclerosis (**[Table 1](#T1){ref-type="table"}**). Transgenes are usually expressed in the liver or macrophages to study their functions (**[Table 2](#T2){ref-type="table"}**). To date, more than 20 genes have been introduced into Tg rabbits, and have provided considerable insight into the molecular mechanisms associated with their functions in lipoprotein metabolism and atherosclerosis^[@bib25])^.

###### Transgenic rabbits for the study of human cardiovascular diseases

  Genes                           Expressing cells   Major phenotypes                                References
  ------------------------------- ------------------ ----------------------------------------------- --------------------
  Apolipoproteins:                                                                                   
      Apo(a)                      Liver              Atherogenic                                     [@bib33]--[@bib37]
      ApoA-I                      Liver              Athero-protective                               [@bib38], [@bib39]
      ApoA-II                     Liver              Athero-protective                               [@bib40], [@bib41]
      ApoB-100                    Liver              LD ↑, HDL ↓                                     [@bib42]
      ApoCIII                     Liver              VLDL ↑                                          [@bib43]
      ApoE2                       Liver              Atherogenic                                     [@bib44]
      ApoE3                       Liver              Atherogenic                                     [@bib45], [@bib46]
  Enzymes:                                                                                           
      Hepatic lipase              Liver              Athero-protective                               [@bib47]
      apoB mRNA editing protein   Liver              LDL ↓                                           [@bib48]
      LCAT                        Liver              Athero-protective                               [@bib49], [@bib50]
      Lipoprotein lipase          Universal          Athero-protective                               [@bib51]
      PLTP                        Universal          Atherogenic                                     [@bib52]
      Endothelial lipase          Liver              Athero-protective                               [@bib53]
  Vascular factors:                                                                                  
      Lipoprotein lipase          Macrophage         Atherogenic                                     [@bib54]
      MMP-12                      Macrophage         Atherogenic                                     [@bib20], [@bib55]
      C-reactive protein          Liver              Thrombogenic                                    [@bib24], [@bib56]
      15-lypooxygenase            Macrophage         Athero-protective                               [@bib57]
      VEGF                        Liver              hemangiomas and impaired glomerular functions   [@bib58], [@bib59]

ND: not done. LCAT, lecithin: cholesterol acyltransferase; PLTP, phospholipid transfer protein; MMP, matrix metalloproteinase; VEGF, vascular endothelial cell growth factor.

Knock-Out Rabbits
=================

For a long time, generation of knock-out rabbits has been a dream for researchers because rabbit embryonic stem (ES) cells are not available and genomic information for rabbits is lacking. Rabbit genome sequencing was initially completed by a European group^[@bib26])^, and two years later, we along with Chinese and US groups, successfully sequenced three rabbit genomes (New Zealand White, Japanese White and Watanabe heritable hyperlipidemic rabbits) and completed transcriptomic profiling of atherosclerotic lesions and the liver for these rabbits^[@bib27])^. These genomic and RNA seq data will provide many insights into understanding the pathogenesis of atherosclerosis in rabbits. Another advancement in this field is the emergence of novel gene-editing technologies (ZFN, TALENs, CRISPR-Cas9) in succession, which has made it possible to make KO rabbits just as KO mice. The first KO rabbits were generated by the ZFN method to target the IgM gene^[@bib28])^, and later, we along with others, successfully generated apoCIII^[@bib29])^ and CETP KO rabbits^[@bib14])^ using the same method. Although TALENs were still used to create KO rabbits^[@bib30])^, CRISPR-Cas9 has now been become the main method for generation of KO rabbits in this field, such as apoE and LDL receptor KO rabbits^[@bib31],\ [@bib32])^ (**[Table 3](#T3){ref-type="table"}**). Therefore, one can predict that in the next few years, through these novel technologies, KO rabbits will be generated and used for translational studies of cardiovascular diseases.

###### KO rabbits recently reported

  Genes                             Methods           Research models                        References
  --------------------------------- ----------------- -------------------------------------- --------------------
  ApoCIII                           ZFN               Atherosclerosis                        [@bib29]
  ApoE                              ZFN/CRISPR/Cas9   Atherosclerosis                        [@bib32], [@bib60]
  CETP                              ZFN               Atherosclerosis                        [@bib14]
  αA-Crystallin/GJA8                CRISPR/Cas9       Congenital Cataracts                   [@bib61], [@bib62]
  Sex-determining region Y          CRISPR/Cas9       Male-to-female sex reversal syndrome   [@bib63]
  Fumarylacetoacetate hydroxylase   TALENs            Tyrosinemia                            [@bib30]
  PHEX                              CRISPR/Cas9       Inheritable rickets                    [@bib64]
  Myostatin                         CRISPR/Cas9       Muscle hypertrophy                     [@bib65]

Advantages and Disadvantages
============================

The rationale of using rabbits rather than mice is dependent upon the research purpose, as described above. As shown in **[Table 1](#T1){ref-type="table"}**, like humans but unlike mice, rabbits have a unique lipid metabolism system which facilitates the study of the human lipid metabolism (**[Table 1](#T1){ref-type="table"}**). Second, rabbit atherosclerosis lesions resemble those of humans, from early to advanced lesions. Third, adult rabbit body weights (2000∼3500 g) are ∼100-fold larger than mice (20∼30 g), thus the large size of rabbits (including their arteries) enables preclinical studies for surgical experiments such as studies on stents and catheters. The large amount of tissue also makes it possible to perform many analyses using a single animal. Finally, it is important to use rabbits to perform translational research such as development of new lipid-lowering therapeutics. Rabbits should not be considered as a simple substitute for rodents because compared with mice, rabbits may have disadvantages. The individual price of adult rabbits (150∼200 US\$ in Japan) is 10-fold higher than for mice (15∼20 US\$). Second, the breeding expense of rabbits (0.6∼1\$ /rabbit/day) is 10-fold more expensive than for mice (0.06\$ per day). Rabbits are kept in individual cages, whereas mice are kept in a cage with a group of 8∼16 mice; therefore, a large space is required for rabbits compared with mice. Being aware of these disadvantages is very important for one to make a decision regarding whether to use rabbits. The most critical point is whether experiments are designed to solve clinical problems such as for translational research.

In conclusion, rabbits are still a powerful model for the study of human atherosclerosis. With the advances in nuclease-editing technology, KO rabbits will provide a new means for translational research in this field. These new models will help develop novel therapeutics and diagnostics for cardiovascular disease in the future.
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